Literature DB >> 16120278

Ascorbate reduces superoxide production and improves mitochondrial respiratory chain function in human fibroblasts with electron transport chain deficiencies.

P Sharma1, P D Mongan, P D Morgan.   

Abstract

The present paper attempts to ascertain the role of ascorbate on the generation of superoxide radicals in skin fibroblasts of patients with deficiency of mitochondrial respiratory chain enzymes. Fibroblast cell lines were grown with or without ascorbate for the last 48 h of their growth period. The amount of superoxide radical production in cells was measured by the reduction of nitroblue tetrazolium and the activities of respiratory chain enzymes were examined in isolated fibroblast mitochondria. The results indicated a significant inverse correlation between the amount of superoxide radicals and the specific activities of complexes I-III and II-III of the respiratory chain. The ascorbate treatment of fibroblasts from control subjects did not show any effect on either superoxide radical production or respiratory chain enzymes' activities. While in patient's fibroblasts, this vitamin significantly decreased the superoxide radicals and increased the specific activities of I-III and II-III complexes but not complex IV. These observations indicate that superoxide radicals are increased in patients with deficient respiratory chain enzymes in their fibroblasts and ascorbate can prevent the loss of these enzymes by acting on the selected sites in the respiratory chain, which are related to the production of free radicals.

Entities:  

Year:  2001        PMID: 16120278     DOI: 10.1016/s1567-7249(01)00016-2

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  8 in total

1.  Thermogenic responsiveness to beta-adrenergic stimulation is augmented in exercising versus sedentary adults: role of oxidative stress.

Authors:  Christopher Bell; Nicole R Stob; Douglas R Seals
Journal:  J Physiol       Date:  2005-11-24       Impact factor: 5.182

2.  Mitochondrial complex IV deficiency, caused by mutated COX6B1, is associated with encephalomyopathy, hydrocephalus and cardiomyopathy.

Authors:  Ulla Najwa Abdulhag; Devorah Soiferman; Ora Schueler-Furman; Chaya Miller; Avraham Shaag; Orly Elpeleg; Simon Edvardson; Ann Saada
Journal:  Eur J Hum Genet       Date:  2014-04-30       Impact factor: 4.246

3.  Comprehensive investigations of key mitochondrial metabolic changes in senescent human fibroblasts.

Authors:  Hazem K Ghneim; Mohammad A Alfhili; Sami O Alharbi; Shady M Alhusayni; Manal Abudawood; Feda S Aljaser; Yazeed A Al-Sheikh
Journal:  Korean J Physiol Pharmacol       Date:  2022-07-01       Impact factor: 1.718

4.  TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction.

Authors:  Nithya Mariappan; Carrie M Elks; Bruno Fink; Joseph Francis
Journal:  Free Radic Biol Med       Date:  2008-11-12       Impact factor: 7.376

Review 5.  Vitamin C: update on physiology and pharmacology.

Authors:  J Mandl; A Szarka; G Bánhegyi
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

6.  Qualitative determination of superoxide release at both sides of the mitochondrial inner membrane by capillary electrophoretic analysis of the oxidation products of triphenylphosphonium hydroethidine.

Authors:  Xin Xu; Edgar A Arriaga
Journal:  Free Radic Biol Med       Date:  2009-01-07       Impact factor: 7.376

7.  The Effects of Ascorbate, N-Acetylcysteine, and Resveratrol on Fibroblasts from Patients with Mitochondrial Disorders.

Authors:  Liza Douiev; Devorah Soiferman; Corinne Alban; Ann Saada
Journal:  J Clin Med       Date:  2016-12-22       Impact factor: 4.241

8.  Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH-).

Authors:  Xuan Zhang; Tiefu Liu; Zehuan Li; Yanling Feng; Christopher Corpe; Shanshan Liu; Jingpu Zhang; Xiaomeng He; Feng Liu; Li Xu; Longqiang Shen; Shun Li; Qianlin Xia; Xiuhua Peng; Xiaohui Zhou; Weiping Chen; Xiaoyan Zhang; Jianqing Xu; Jin Wang
Journal:  Theranostics       Date:  2019-10-18       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.